在SAPIEN 3门中调整:对随访时的梯度和死亡率的影响
Leire Unzue1,2, Belén Díaz Antón2,3, Adrián Peláez Laderas2,4,5
1Departamento de Cardiología Intervencionista, HM CIEC MADRID (Centro Integral de Enfermedades Cardiovasculares), HM Hospitales, Madrid, Spain.
概括
在40%的SAPIEN 3门患者中发生了门错位 (CMA),但没有影响长期死亡率或梯度增加. 这项研究评估了SAPIEN 3门中的CMA,并没有发现与不良结果的显著关联.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 自扩展门的门错位 (CMA) 可以使未来的冠状动脉接入复杂化,并与叶片血栓症和增加的门梯度有关.
- 了解气球膨胀门的CMA对于长期结果至关重要.
研究的目的:
- 为了评估SAPIEN 3门的指南针对齐.
- 为了确定CMA对跨膜梯度和5年随访后死亡率的影响.
主要方法:
- 经食道回声心图 (TEE) 用于测量SAPIEN 3门部署后的105名患者的指导管对齐.
- 在CMA的定义中,与本地委托相比,新委托偏差>30°.
- 听力心电图梯度和临床事件被追踪了5年.
主要成果:
- 40%的患者表现出显著的CMA (>30°).
- 错位的患者有较小的主动脉环,并获得较小的门.
- 随着时间的推移,观察到平均跨膜梯度略有增加,但在对齐和不对齐的组之间没有显著差异.
- 5年死亡率为49.5%,与CMA无关.
结论:
- 在SAPIEN 3门中常见的是显著的指导管 misalignment.
- 在这个队列中,CMA与增加的横膜梯度或长期死亡率没有相关性.
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation I: Introduction
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


